Springhorn Jeremy P. sold $54K of QURE
Springhorn Jeremy P. sold 1,993 shares of uniQure N.V. (QURE) at $27.06 on 2026-06-11.
How this was made
The 30-second read
Why it matters
The only new fact is the director’s open-market sale details (shares, price, and post-transaction holdings).
Market read
Traders may monitor for follow-on insider activity, but this filing alone does not change uniQure’s fundamentals.
What to watch
The absence of a stated 10b5-1 plan can increase speculation, but without additional context (e.g., prior planned sales, compensation structure) it’s not a reliable signal.
Background
The article is an SEC EDGAR Form 4 insider transaction disclosure for uniQure N.V. (QURE).
Ticker impact
uniQure director Jeremy P. Springhorn sold 1,993 shares in an open-market transaction on 2026-06-11, per SEC Form 4.
Likely minimal near-term impact; any effect would be sentiment-only and short-lived.
The filing is a Form 4 insider transaction with no accompanying company news (no guidance, trial, deal, or regulatory action) and no 10b5-1 plan disclosed.
Market effects
No clear read-through to the gene-therapy/biotech sector from a single director sale.
None indicated.
None indicated.
Counterpoint
Because the sale is small relative to typical institutional float and lacks any fundamental accompanying event, it may be driven by diversification or taxes rather than negative outlook.
Key entities
- issueruniQure N.V.
Subject of the SEC Form 4 insider transaction disclosure.
- directorJeremy P. Springhorn
Director who sold 1,993 shares on 2026-06-11.
